找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Enzyme-Prodrug Strategies for Cancer Therapy; Roger G. Melton,Richard J. Knox Book 1999 Springer Science+Business Media New York 1999 bioc

[復(fù)制鏈接]
查看: 19942|回復(fù): 41
樓主
發(fā)表于 2025-3-21 17:34:26 | 只看該作者 |倒序?yàn)g覽 |閱讀模式
書目名稱Enzyme-Prodrug Strategies for Cancer Therapy
編輯Roger G. Melton,Richard J. Knox
視頻videohttp://file.papertrans.cn/314/313104/313104.mp4
圖書封面Titlebook: Enzyme-Prodrug Strategies for Cancer Therapy;  Roger G. Melton,Richard J. Knox Book 1999 Springer Science+Business Media New York 1999 bioc
描述Antibody-directed enzyme prodrug therapy (ADEPT) directlyaddresses the major problem in cancer chemotherapy-its lack ofselectivity. Antibody delivery combined with the amplificationprovided by the enzymatic activation of prodrugs enables selection tobe made between tumour and normal tissue. ADEPT offers a novel fieldof opportunities in the therapy of systemic cancer and may be a majoradvance for the treatment of solid tumours..This book is the first to describe ADEPT in detail. Each chapterreviews an aspect of the immunology, enzymology, biochemistry,chemistry, and cancer chemotherapy which have been integrated into theADEPT concept. An additional chapter describes the related approach ofgene-directed enzyme prodrug therapy (GDEPT). This latter approach isstill in its infancy but ADEPT has entered the clinic. The initialclinical studies with ADEPT are included and discussed in detail.
出版日期Book 1999
關(guān)鍵詞biochemistry; cancer; chemistry; chemotherapy; enzyme; enzymes; immunology; protein; proteins; synthesis; tiss
版次1
doihttps://doi.org/10.1007/978-1-4615-4823-2
isbn_softcover978-1-4613-7186-1
isbn_ebook978-1-4615-4823-2
copyrightSpringer Science+Business Media New York 1999
The information of publication is updating

書目名稱Enzyme-Prodrug Strategies for Cancer Therapy影響因子(影響力)




書目名稱Enzyme-Prodrug Strategies for Cancer Therapy影響因子(影響力)學(xué)科排名




書目名稱Enzyme-Prodrug Strategies for Cancer Therapy網(wǎng)絡(luò)公開度




書目名稱Enzyme-Prodrug Strategies for Cancer Therapy網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Enzyme-Prodrug Strategies for Cancer Therapy被引頻次




書目名稱Enzyme-Prodrug Strategies for Cancer Therapy被引頻次學(xué)科排名




書目名稱Enzyme-Prodrug Strategies for Cancer Therapy年度引用




書目名稱Enzyme-Prodrug Strategies for Cancer Therapy年度引用學(xué)科排名




書目名稱Enzyme-Prodrug Strategies for Cancer Therapy讀者反饋




書目名稱Enzyme-Prodrug Strategies for Cancer Therapy讀者反饋學(xué)科排名




單選投票, 共有 0 人參與投票
 

0票 0%

Perfect with Aesthetics

 

0票 0%

Better Implies Difficulty

 

0票 0%

Good and Satisfactory

 

0票 0%

Adverse Performance

 

0票 0%

Disdainful Garbage

您所在的用戶組沒有投票權(quán)限
沙發(fā)
發(fā)表于 2025-3-21 21:41:43 | 只看該作者
Phage Technology for Producing Antibody-Enzyme Fusion Proteins,e of ADEPT systems is that they potentially include an amplification step (each enzyme molecule produces many molecules of the active drug within the tumor) and a bystander effect (destruction of neighboring cells and those binding the antibody fragment) because the final cytotoxic molecule is produ
板凳
發(fā)表于 2025-3-22 02:17:31 | 只看該作者
地板
發(fā)表于 2025-3-22 07:30:17 | 只看該作者
https://doi.org/10.1007/978-1-349-17617-5e of ADEPT systems is that they potentially include an amplification step (each enzyme molecule produces many molecules of the active drug within the tumor) and a bystander effect (destruction of neighboring cells and those binding the antibody fragment) because the final cytotoxic molecule is produ
5#
發(fā)表于 2025-3-22 12:01:09 | 只看該作者
Introduction,elves and have proved very difficult to overcome. To date, there have been numerous attempts to improve the cytotoxicity of the antibody “missile” by attaching a variety of “warheads” to them, for example, cytotoxic drugs, such as adriamycin or methotrexate, toxins, such as ricin A-chain or . exotoxin, and radioisotopes (.).
6#
發(fā)表于 2025-3-22 16:39:40 | 只看該作者
7#
發(fā)表于 2025-3-22 17:51:19 | 只看該作者
8#
發(fā)表于 2025-3-23 00:30:24 | 只看該作者
9#
發(fā)表于 2025-3-23 02:20:26 | 只看該作者
Enzymes and Prodrugs Used for ADEPT,out a hundredfold the equivalent of a normal clinical dose of present day agents. However, this cannot be achieved because of the toxic effect on the normal most rapidly dividing host tissues, such as bone marrow, gut mucosa, and the lymphatic system.
10#
發(fā)表于 2025-3-23 08:16:02 | 只看該作者
The Design and Synthesis of Prodrugs for Antibody-Directed Enzyme Prodrug Therapy (ADEPT),toxic prodrug is administered which releases a therapeutic drug on contact with the enzyme. This two-step approach has the potential to overcome many of the limitations of current chemotherapeutic strategies, allow the generation of high intratumoral concentrations of drug, and minimize damage to normal tissues.
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-10 12:39
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
汝南县| 余江县| 齐齐哈尔市| 嘉义县| 通许县| 三门峡市| 临邑县| 康保县| 漳平市| 商丘市| 江山市| 南宫市| 靖边县| 江安县| 屏南县| 广南县| 牙克石市| 龙陵县| 嫩江县| 东源县| 屏边| 黄山市| 钟祥市| 洛南县| 镇巴县| 玉田县| 罗源县| 眉山市| 彝良县| 长沙市| 阜宁县| 满洲里市| 汽车| 历史| 长岭县| 台安县| 渑池县| 庆元县| 沙田区| 介休市| 湟源县|